Economic evidence is increasingly being used for informing health policies. However, the
underlining principles of health economic analyses are not always fully understood by non …

In this second part of a 2-part series on the global burden of cardiovascular disease, we
review the proven, effective approaches to the prevention and treatment of cardiovascular …

Background Assessment of the efficiency of interventions is paramount to achieving
equitable health-care systems. One key barrier to the widespread use of economic …

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …

Background: Cost-effectiveness analysis is an important tool for informing treatment
coverage and pricing decisions, yet no consensus exists about what threshold for the …

The economic evaluation of healthcare interventions requires an assessment of whether the
improvement in health outcomes they offer exceeds the improvement in health that would …

An inverse care law persists in almost all low-income and middle-income countries, whereby
socially disadvantaged people receive less, and lower-quality, health care despite having …

Background Decision-making in healthcare policy involves assessing both costs and
benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP) per …

Background Obstructive sleep apnea (OSA) is a risk factor for several diseases and is
correlated with other non-medical consequences that increase the disease's clinical and …

Background Policymakers in high-, low-, and middle-income countries alike face
challenging choices about resource allocation in health. Economic evaluation can be useful …